| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2020 | Aug 11, 2020 | iBio, Inc. | 10% Owner | Sell | 15.0 | -24,484,904 | -73.94% | ✗ | $79.9M |
| Aug 4, 2020 | Aug 6, 2020 | iBio, Inc. | 10% Owner | Sell | 15.0 | -4,268,137 | -11.42% | ✗ | $18.2M |
| Jul 12, 2018 | Jul 13, 2018 | iBio, Inc. | 10% Owner | Buy | 100.0 | +2,200,000 | 35.16% | ✗ | $2M |
| Jun 26, 2018 | Jun 28, 2018 | iBio, Inc. | 10% Owner | Buy | 100.0 | +1,683,334 | 36.80% | ✗ | $1.5M |
| May 14, 2018 | May 16, 2018 | Marker Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,300,000 | 32.50% | ✗ | $3.1M |
| Nov 30, 2017 | Dec 4, 2017 | iBio, Inc. | 10% Owner | Buy | 100.0 | +12,000,000 | 35.56% | ✗ | $2.4M |
| Jul 19, 2017 | Jul 21, 2017 | Cyclacel Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +850,000 | 64.53% | ✗ | $1.7M |
| Apr 7, 2016 | Apr 11, 2016 | iBio, Inc. | 10% Owner | Buy | 100.0 | +6,500,000 | 23.86% | ✗ | $4M |
| Jan 25, 2016 | Jan 27, 2016 | iBio, Inc. | 10% Owner | Buy | 100.0 | +3,500,000 | 15.94% | ✗ | $2.2M |